| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
1 company
Jeffrey M Rowe is Director at ZOMDF. Jeffrey M Rowe's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $159K at current prices.
Net of sales, the ZOMDF filings show accumulation of 1,439,005 shares.
Jeffrey M Rowe has 9 Form 4 filings on record from March 2018 to November 2025, all as Director at Zomedica (ZOMDF), 2018–2025.
The 14 reported transactions were 6 option or other derivative awards, 6 open-market purchases and 2 option exercises.
Counted by filing, the open-market trades come to 1 purchase worth about $96K and no sales.
The only open-market purchase was 1,439,005 shares of ZOMDF at an average $0.07 on March 17, 2025, about $96K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | ZOMDF Zomedica Corp. | Director | Buy | 1,439,005 | $0.07 | $96,098.34 | +523.3% |